Analgesia in the Second Stage of Labour
ASL
1 other identifier
observational
1,007
0 countries
N/A
Brief Summary
This study investigates efficacy, safety and childbirth experience in women receiving pudendal block during the final stage of delivery. It is an observational study and half of included primarous women recieve a pudendal block.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2019
CompletedFirst Submitted
Initial submission to the registry
May 12, 2020
CompletedFirst Posted
Study publicly available on registry
May 18, 2020
CompletedMay 19, 2020
May 1, 2020
2.3 years
May 12, 2020
May 15, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Childbirth experience
Childbirth experience questionnaire (CEQ), total score on a scale from 1.0 to 4.0. Higher score means better experience.
Responds to questionnaire 4-12 weeks after delivery.
Urinary retention
Urinary retention after delivery defined as inability to void and need for catheterization within 3 hours.
3 hours
Secondary Outcomes (1)
Pain, obstetric
Responds to questionnaire 4-12 weeks after delivery.
Study Arms (2)
Exposed
Pudendal nerve block provided
Not exposed
Pudendal nerve block is NOT provided
Interventions
Eligibility Criteria
The participants is selected from 2 delivery units at Oslo Univeristy Hospital (OUH) in Oslo, Norway. OUH is a third referral hospital, the largest Obstetrics Dept. in Norway, and accounting for 1/6 of all deliveries in Norway (9600 deliveries/year).
You may qualify if:
- Norwegian-speaking/reading
- Primiparity
- Single pregnancy
- Vaginal birth
- Cephalic presentation
- ≥37+0
- Age ≥18 years
You may not qualify if:
- Transferre from midwifery-led birth unit
- Allergy to local anaesthesia
- Not valid data on pudendal block
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne Flem Jacobsen, PhD
Univeristy of Oslo
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Midwife/PhD student
Study Record Dates
First Submitted
May 12, 2020
First Posted
May 18, 2020
Study Start
January 1, 2017
Primary Completion
May 1, 2019
Study Completion
May 31, 2019
Last Updated
May 19, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Data will be available on request within 1 year after study completion.
- Access Criteria
- Data access will be considered on specific request. Requestors wil be required to sign a Data Access Agreement.
Anonymous individual participant data for the primary outcome measures will be made available on request, when the study is finished. Access to data will be restricted due to sensitive nature of the data, but will be shared if asked for within the anonymous data restriction imposed by the patient consent and ethical body approval.